Major owner of Corvus Pharmaceuticals, Inc. just disposed of 1,492,956 shares

Holdings A/S Novo, a major owner of Corvus Pharmaceuticals, Inc., recently disposed of 1,492,956 shares of the company. The disposals took place at prices ranging from $4.00 to $5.32 per share, on dates ranging from July 23 to July 25, 2019. Novo still owns 2,927,560 shares of the company. Novo operates out of Hellerup, G7. Some additional info was provided as follows:


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.25 to $5.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Corvus Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

On September - Sept. 17, 2020
Corvus Pharmaceuticals, Inc. director was just granted 30,000 options - Sept. 15, 2020
Corvus Pharmaceuticals, Inc. director just declared 0 ownership of the company. - Sept. 15, 2020
Departure of Directors or Certain - Sept. 11, 2020
On September - Sept. 10, 2020

Auto Refresh

Feedback